LCG
EGRX

Lisanti Capital Growth’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Lisanti Capital Growth’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,995
Closed -$714K – 116
2016
Q4 		$714K Buy
+8,995
New +$714K 0.86% 59